Anuh Pharma gains on receiving approval from WHO-Geneva Prequalification

05 Aug 2019 Evaluate

Anuh Pharma is currently trading at Rs. 110.00, up by 0.75 points or 0.69% from its previous closing of Rs. 109.25 on the BSE.

The scrip opened at Rs. 109.00 and has touched a high and low of Rs. 111.40 and Rs. 105.15 respectively. So far 2391 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 189.80 on 31-Aug-2018 and a 52 week low of Rs. 101.25 on 02-Aug-2019.

Last one week high and low of the scrip stood at Rs. 125.00 and Rs. 101.25 respectively. The current market cap of the company is Rs. 276.24 crore.

The promoters holding in the company stood at 71.78% while Non-Institutions held 28.22% stake in the company.

Anuh Pharma has received approval from WHO - Geneva Prequalification that the Prequalification Inspection Group has recommended that the API's Pyrimethamine, Pyrazinamide and Sulfadoxine can be considered to be compliant with the standards of Good Manufacturing Practices (GMP) for Active Pharmaceutical Ingredients (APIs) published by the World Health Organisation (WHO) for manufacturing and packaging of APIs by chemical synthesis.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Share Price

82.55 3.39 (4.28%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×